This suggests that APOE ε4 may affect the occurrence of ARIA through a dual mechanism—both by exacerbating the severity of cerebral amyloid angiopathy (CAA) and by amplifying the blood-brain barrier disruption effect through apolipoprotein E-mediated inflammatory responses. This evidence concerns the gene APOE and cerebral amyloid angiopathy.